![Melissa McBurnie](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Melissa McBurnie
Presidente en MetabloQ Pty Ltd. .
Cargos activos de Melissa McBurnie
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Brandon Capital Partners Pty Ltd.
![]() Brandon Capital Partners Pty Ltd. Investment ManagersFinance Brandon Capital Partners Pty Ltd. (Brandon Capital Partners) is a venture capital firm founded in 2007 by David Fisher and Chris Nave. The firm is headquartered in Sydney, Australia. | Inversor de Capital Privado | 01/01/2008 | - |
MetabloQ Pty Ltd.
![]() MetabloQ Pty Ltd. BiotechnologyHealth Technology MetabloQ Pty Ltd. develops drugs for cancer treatment. It treats triple-negative breast cancer, prostate cancer and melanoma cancer diseases. The company was founded in 2016 and is headquartered in Melbourne, Australia. | Presidente | - | - |
Ankere Therapeutics
![]() Ankere Therapeutics BiotechnologyHealth Technology Ankere Therapeutics develops therapeutics for inflammatory diseases. The Australian company was founded by Stuart Pitson, Bernard Flynn. Bernard Flynn has been the CEO since incorporation. | Director/Miembro de la Junta | - | - |
Historial de carrera de Melissa McBurnie
Formación de Melissa McBurnie.
University of Adelaide | Graduate Degree |
Estadísticas
Internacional
Australia | 5 |
Operativa
Private Equity Investor | 1 |
Chairman | 1 |
Graduate Degree | 1 |
Sectorial
Health Technology | 3 |
Finance | 2 |
Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas privadas | 3 |
---|---|
Brandon Capital Partners Pty Ltd.
![]() Brandon Capital Partners Pty Ltd. Investment ManagersFinance Brandon Capital Partners Pty Ltd. (Brandon Capital Partners) is a venture capital firm founded in 2007 by David Fisher and Chris Nave. The firm is headquartered in Sydney, Australia. | Finance |
MetabloQ Pty Ltd.
![]() MetabloQ Pty Ltd. BiotechnologyHealth Technology MetabloQ Pty Ltd. develops drugs for cancer treatment. It treats triple-negative breast cancer, prostate cancer and melanoma cancer diseases. The company was founded in 2016 and is headquartered in Melbourne, Australia. | Health Technology |
Ankere Therapeutics
![]() Ankere Therapeutics BiotechnologyHealth Technology Ankere Therapeutics develops therapeutics for inflammatory diseases. The Australian company was founded by Stuart Pitson, Bernard Flynn. Bernard Flynn has been the CEO since incorporation. | Health Technology |
- Bolsa de valores
- Insiders
- Melissa McBurnie
- Experiencia